id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-P-3404-0004,FDA,FDA-2015-P-3404,"Determination That LIPTRUZET (Ezetimibe and Atorvastatin) Tablets,
10 Milligrams/10 Milligrams, 10 Milligrams/20 Milligrams, 10
Milligrams/40 Milligrams, and 10 Milligrams/80 Milligrams, Were Not
Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2015-11-20T05:00:00Z,2015,11,2015-11-20T05:00:00Z,,2015-12-01T20:22:32Z,2015-29639,0,0,0900006481d5e0b2
FDA-2015-P-3404-0005,FDA,FDA-2015-P-3404,"Letter from FDA CDER to Lupin Pharmaceuticals, Inc.",Other,Letter(s),2015-11-20T05:00:00Z,2015,11,2015-11-20T05:00:00Z,,2015-11-20T22:03:18Z,,0,0,0900006481d61232
FDA-2015-P-3404-0003,FDA,FDA-2015-P-3404,"Acknowledgement Letter from FDA DDM to Lupin Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2015-09-25T04:00:00Z,2015,9,2015-09-25T04:00:00Z,,2015-09-25T15:49:00Z,,0,0,0900006481c8f3b4
FDA-2015-P-3404-0002,FDA,FDA-2015-P-3404,"Attachment 1 Prescription and Over the Counter Drug Product List from the Orange Book re Citizen Petition from Lupin Pharmaceuticals, Inc.",Supporting & Related Material,Background Material,2015-09-25T04:00:00Z,2015,9,,,2015-09-25T15:48:46Z,,0,0,0900006481c8f3b3
FDA-2015-P-3404-0001,FDA,FDA-2015-P-3404,"Citizen Petition from Lupin Pharmaceuticals, Inc.",Other,Citizen Petition,2015-09-25T04:00:00Z,2015,9,2015-09-25T04:00:00Z,,2024-11-11T21:04:04Z,,1,0,0900006481c8f3b1